Core Insights - Albemarle Corporation (ALB) reported an adjusted loss of 53 cents per share in Q4 2025, compared to a loss of $1.09 per share a year ago, which was wider than the Zacks Consensus Estimate of a loss of 40 cents [1] Revenue Performance - Revenues increased by approximately 15.9% year over year to $1,428 million in the quarter, surpassing the Zacks Consensus Estimate of $1,349.8 million, driven by higher volumes in Energy Storage and Ketjen, as well as increased pricing in Energy Storage [2] - Adjusted EBITDA for the quarter was $268.7 million, up from $250.7 million in the prior-year quarter, fueled by higher pricing in Energy Storage and increased volumes in Ketjen [2] Segment Highlights - Sales from the Energy Storage unit rose around 23.1% year over year to $759.1 million, exceeding the consensus estimate of $717 million, attributed to higher volumes and pricing [3] - The Specialties segment recorded sales of $348.9 million, up around 4.8% year over year, in line with the consensus estimate, benefiting from higher volumes and pricing [3] - The Ketjen unit generated revenues of $320.1 million, up roughly 13.5% year over year, beating the consensus estimate of $296 million, driven by higher fluidized catalytic cracking volumes and timing of Clean Fuels technology [4] Financial Position - Albemarle ended the quarter with cash and cash equivalents of approximately $1,618 million, an increase from $1,192.2 million reported in the prior-year quarter, while long-term debt remained around $3,119.5 million [5] - Cash from operations for the year ended December 31, 2025, was around $1.3 billion, reflecting an 85% increase from the prior-year period [5] 2026 Outlook - Albemarle anticipates energy storage sales volumes to be roughly flat in 2026 following inventory drawdowns in 2025, with modest volume growth expected in the Specialties segment, projecting net sales to be flat to down year over year [6] - The sale of the Ketjen unit is expected to close in the first quarter of 2026 [6] Expenses Forecast - Depreciation and amortization expenses are expected to be between $660 million and $680 million for 2026, with capital expenditures projected at $550 million to $600 million, and interest and financing expenses forecasted at $150 million to $170 million for the full year [7] Stock Performance - Albemarle's shares have increased by 116.5% over the past year, contrasting with a 11.9% decline in the Zacks Chemicals Diversified industry [8]

Core Insights - Albemarle reported revenue of $1.43 billion for the quarter ended December 2025, reflecting a 15.9% increase year-over-year and a 5.8% surprise over the Zacks Consensus Estimate of $1.35 billion [1] - The company's EPS was -$0.53, an improvement from -$1.09 in the same quarter last year, but fell short of the consensus estimate of -$0.40, resulting in a 33% negative surprise [1] Revenue Performance - Net Sales in Energy Storage reached $759.06 million, exceeding the average estimate of $716.89 million by five analysts, marking a year-over-year increase of 23.1% [4] - Net Sales for Ketjen were reported at $320.07 million, surpassing the average estimate of $296.35 million, with a year-over-year change of 13.5% [4] - Net Sales in Specialties amounted to $348.9 million, slightly above the average estimate of $348.66 million, reflecting a year-over-year increase of 4.8% [4] EBITDA Analysis - Adjusted EBITDA for Corporate was reported at -$16.54 million, which was below the average estimate of -$15.46 million by five analysts [4] - Adjusted EBITDA for Ketjen was $49.68 million, significantly higher than the average estimate of $35.01 million [4] - Adjusted EBITDA for Specialties reached $68.55 million, exceeding the average estimate of $52.12 million [4] - Adjusted EBITDA for Energy Storage was reported at $167.06 million, slightly above the average estimate of $159.67 million [4] Stock Performance - Albemarle's shares have returned -4.7% over the past month, compared to a -0.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating potential for outperformance in the near term [3]

Core Insights - Albemarle reported revenue of $1.31 billion for the quarter ended September 2025, a decrease of 3.5% year-over-year, but exceeded the Zacks Consensus Estimate by 1.23% [1] - The company posted an EPS of -$0.19, significantly improved from -$1.55 in the same quarter last year, resulting in an EPS surprise of 79.35% compared to the consensus estimate of -$0.92 [1] Financial Performance - Net Sales in Energy Storage reached $708.76 million, surpassing the average estimate of $677.78 million, but reflecting a year-over-year decline of 7.6% [4] - Net Sales in Ketjen amounted to $254.11 million, exceeding the average estimate of $248.28 million, with a year-over-year increase of 3.7% [4] - Net Sales in Specialties were reported at $344.96 million, slightly below the average estimate of $348.57 million, showing a year-over-year change of 0.8% [4] Adjusted EBITDA - Adjusted EBITDA for Corporate was -$7.56 million, better than the average estimate of -$15.73 million [4] - Adjusted EBITDA for Ketjen was $33.57 million, exceeding the average estimate of $25.81 million [4] - Adjusted EBITDA for Specialties reached $75.54 million, surpassing the average estimate of $68.89 million [4] - Adjusted EBITDA for Energy Storage was $124.08 million, above the average estimate of $112.09 million [4] Stock Performance - Albemarle's shares have returned -2.3% over the past month, contrasting with a +1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Albemarle reported $1.08 billion in revenue for Q1 2025, a year-over-year decline of 20.9% and below the Zacks Consensus Estimate of $1.17 billion, resulting in a surprise of -8.07% [1] - The company experienced an EPS of -$0.18, compared to $0.26 a year ago, with an EPS surprise of +70.97% against a consensus estimate of -$0.62 [1] Revenue Performance - Net Sales in Energy Storage were $524.57 million, down 34.5% year-over-year and below the average estimate of $588.57 million [4] - Net Sales for Ketjen were $231.30 million, a decrease of 5.1% year-over-year, compared to the estimated $243.93 million [4] - Net Sales in Specialties reached $321.01 million, showing a slight increase of 1.6% year-over-year, but below the average estimate of $329.98 million [4] EBITDA Analysis - Adjusted EBITDA for Energy Storage was $186.36 million, exceeding the average estimate of $132.93 million [4] - Adjusted EBITDA for Corporate was -$16.47 million, worse than the average estimate of -$9.39 million [4] - Adjusted EBITDA for Ketjen was $38.59 million, surpassing the average estimate of $27.55 million [4] - Adjusted EBITDA for Specialties was $58.67 million, slightly above the average estimate of $55.43 million [4] Stock Performance - Albemarle's shares have returned -17.2% over the past month, contrasting with the Zacks S&P 500 composite's -0.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]